Functional Lung Avoidance for Individualized Radiotherapy (FLAIR): A Randomized, Double-Blind Clinical Trial
Stopped Insufficient accrual
Conditions
- Non-small Cell Lung Cancer
Interventions
- DRUG: Concurrent platinum-based chemotherapy
- RADIATION: Standard Radiotherapy, 60 Gy in 30 fractions.
- RADIATION: Functional Lung Avoidance Radiotherapy, 60 Gy in 30 fractions
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's